Antileukemic Effect of Chronic Graft-versus-Host Disease
Paul L. Weiden(Seattle University), Nancy Flournoy(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Keith M. Sullivan(National Cancer Institute), Rainer Storb(City Of Hope National Medical Center), E. Donnall Thomas(AbbVie (United States))
Cited by 1,092
Related Papers
Chronic graft-versus-host syndrome in man
|The American Journal of Medicine|1980|2.4k
HLA-Haploidentical Bone Marrow Transplantation for Hematologic Malignancies Using Nonmyeloablative Conditioning and High-Dose, Posttransplantation Cyclophosphamide
|Biology of Blood and Marrow Transplantation|2008|1.9k
Reconstitution of Cellular Immunity against Cytomegalovirus in Recipients of Allogeneic Bone Marrow by Transfer of T-Cell Clones from the Donor
|New England Journal of Medicine|1995|1.8k
Methotrexate and Cyclosporine Compared with Cyclosporine Alone for Prophylaxis of Acute Graft versus Host Disease after Marrow Transplantation for Leukemia
|New England Journal of Medicine|1986|1.5k